MASTER PRODUCT DEVELOPMENT AND COLLABORATION AGREEMENT BY AND AMONG RICONPHARMA LLC AND ANIP ACQUISITION COMPANY d/b/a ANI PHARMACEUTICALS, INC. JULY 2011Master Product Development and Collaboration Agreement • March 15th, 2022 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 15th, 2022 Company Industry JurisdictionThis MASTER PRODUCT DEVELOPMENT AND COLLABORATION AGREEMENT is made as of the 11th day of July 2011, by and among ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (“ANI”), having a place of business at 210 Main Street West, Baudette, MN 56623 and RiconPharma LLC, a limited liability company having its principal office at 100 Ford Road, Suite #9, Denville, NJ 07834 (“RiconPharma”). ANI and RiconPharma may each be referred to herein individually as a “Party” and collectively as the “Parties.”